Covid Vaccine Safety Update
COVID19 - CORONAVIRUS, 19 Apr 2021
17 Apr 2021 – A new study by the University of Oxford reports that the risk of cerebral venous thrombosis (CVT, i.e. blood clots in the brain) after covid vaccinations is about 8 to 10 times lower than after covid disease (4 to 5 per million vs. 39 per million). Moreover, the study indicates that the risk of CVT is in fact similar after AstraZeneca (adenovector) and after Pfizer and Moderna (mRNA) vaccines.
But the study overestimates the CVT risk after covid, because the analysis was based on a US health records network comprising “hospitals, primary care, and specialist providers”, whereas most people with mild covid don’t visit a doctor or a hospital. Furthermore, the study underestimates the CVT risk after vaccinations, because it included everyone who had received “a first dose of the vaccine”, whereas side effects are generally more severe after the second dose.
Adjusting for these two biases, the CVT risk after full vaccination could be equal to or higher than the risk after covid itself. The main difference is that CVT caused by covid affects primarily older people with more comorbidities (as the Oxford study confirms), whereas CVT caused by vaccines affects also, and perhaps even more so, young and healthy people (which is why it was noticed). In other words, the vaccines may cause symptoms of severe covid in young people at very low risk of severe covid.
In addition, confirmed cerebral venous thrombosis is not a major cause of death after covid vaccinations. The major causes of post-vaccination deaths, according to official reporting systems, are ‘general disorders’, ‘cardiac disorders’ (e.g. heart failure, heart attacks), ‘nervous system disorders’, ‘respiratory disorders’ (e.g. blood clots in the lung), and general ‘vascular disorders’.
Conclusion: Covid vaccines are generally effective, at least against current virus variants, but they are not mature medical products meeting the highest medical safety standards. There are already more than 5,000 post-vaccination deaths reported in the US and in Europe, and given underreporting and reporting backlogs, the real figure may be significantly higher. In Israel, an unexplained increase in all-cause mortality after the vaccination campaign has been registered.
Related (18+): An updated social media collection of vaccine adverse events
See also: Vaccines: Successes and Controversies (15 documentaries)
Swiss Policy Research, founded in 2016, is an independent, nonpartisan and nonprofit research group investigating geopolitical propaganda in Swiss and international media. SPR is composed of independent academics that for personal and professional reasons prefer to protect their identities, and receives no external funding; there are no financial sponsors or backers. Our articles have been published or shared by numerous independent media outlets and journalists, among them Julian Assange, and have been translated into more than two dozen languages.
Tags: COVID-19, Coronavirus, Vaccines
DISCLAIMER: The statements, views and opinions expressed in pieces republished here are solely those of the authors and do not necessarily represent those of TMS. In accordance with title 17 U.S.C. section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. TMS has no affiliation whatsoever with the originator of this article nor is TMS endorsed or sponsored by the originator. “GO TO ORIGINAL” links are provided as a convenience to our readers and allow for verification of authenticity. However, as originating pages are often updated by their originating host sites, the versions posted may not match the versions our readers view when clicking the “GO TO ORIGINAL” links. This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
Join the discussion!
We welcome debate and dissent, but personal — ad hominem — attacks (on authors, other users or any individual), abuse and defamatory language will not be tolerated. Nor will we tolerate attempts to deliberately disrupt discussions. We aim to maintain an inviting space to focus on intelligent interactions and debates.
Click here to go to the current weekly digest or pick another article:
COVID19 - CORONAVIRUS: